Niagen Bioscience, Inc. (FRA:OCD1)
Germany · Delayed Price · Currency is EUR 5.35
0.00 (0.00%)
At close: Jan 9, 2026
Niagen Bioscience Market Cap
Niagen Bioscience has a market cap or net worth of €448.92 million as of January 9, 2026. Its market cap has increased by 15.04% in one year.
Market Cap
448.92M
Enterprise Value
396.41M
Revenue
106.29M
Ranking
n/a
PE Ratio
25.78
Stock Price
€5.35
Market Cap Chart
Since June 24, 2008, Niagen Bioscience's market cap has increased from 67.39M to 448.92M, an increase of 566.10%. That is a compound annual growth rate of 11.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 448.92M | 3.48% |
| Dec 31, 2025 | 433.83M | 10.60% |
| Dec 31, 2024 | 392.25M | 302.70% |
| Dec 29, 2023 | 97.41M | -17.00% |
| Dec 30, 2022 | 117.35M | -47.82% |
| Dec 31, 2021 | 224.88M | -7.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |